|
NUP43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.761900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.026000E-02 |
| Normal-vs-Stage2 |
1.850970E-01 |
| Normal-vs-Stage3 |
2.402300E-02 |
| Normal-vs-Stage4 |
2.530000E-01 |
| Stage1-vs-Stage2 |
7.365400E-01 |
| Stage1-vs-Stage3 |
5.761800E-01 |
| Stage1-vs-Stage4 |
5.241200E-01 |
| Stage2-vs-Stage3 |
5.015000E-01 |
| Stage2-vs-Stage4 |
8.234600E-01 |
| Stage3-vs-Stage4 |
3.420600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.563900E-02 |
| Normal-vs-AfricanAmerican |
7.333400E-01 |
| Normal-vs-Asian |
3.504100E-02 |
| Caucasian-vs-AfricanAmerican |
4.302300E-02 |
| Caucasian-vs-Asian |
6.726000E-01 |
| AfricanAmerican-vs-Asian |
5.562400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.850100E-02 |
| Normal-vs-Female |
3.108100E-02 |
| Male-vs-Female |
9.618400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.074000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.472500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.399980E-01 |
| Normal-vs-Age(81-100Yrs) |
1.909370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.481200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.325400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.607800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.840400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.723600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.407400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.187240E-01 |
| Classical-VS-Follicular |
5.346000E-02 |
| Classical-VS-Other |
2.916800E-01 |
| Classical-VS-Normal |
1.657420E-01 |
| Tall-VS-Follicular |
8.069800E-01 |
| Tall-VS-Other |
8.130200E-01 |
| Tall-VS-Normal |
4.246400E-02 |
| Follicular-VS-Other |
7.230200E-01 |
| Follicular-VS-Normal |
2.229900E-02 |
| Other-VS-Normal |
1.699760E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.868100E-02 |
| Normal-vs-N1 |
4.021600E-02 |
| N0-vs-N1 |
6.457600E-01 |
|
|
